{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T16:00:28Z","timestamp":1790438428114,"version":"4.1.0"},"reference-count":139,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.intimp.2026.117310","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T16:11:21Z","timestamp":1787155881000},"page":"117310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["NLRP3 inflammasome and Epstein\u2013Barr virus: mutual regulation and therapeutic potential"],"prefix":"10.1016","volume":"188","author":[{"given":"Jing","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lufan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingmiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2026.117310_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104357","article-title":"Epigenomic landscape study reveals molecular subtypes and EBV-associated regulatory epigenome reprogramming in nasopharyngeal carcinoma","volume":"86","author":"Ka-Yue Chow","year":"2022","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.intimp.2026.117310_bb0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00432-021-03824-y","article-title":"Estimating the global burden of Epstein-Barr virus-related cancers","volume":"148","author":"Wong","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.intimp.2026.117310_bb0015","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.molmed.2024.10.004","article-title":"Advances in Hodgkin lymphoma research","volume":"31","author":"K\u00fcppers","year":"2025","journal-title":"Trends Mol. Med."},{"issue":"2","key":"10.1016\/j.intimp.2026.117310_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011954","article-title":"Epstein-Barr virus lytic gene BNRF1 promotes B-cell lymphomagenesis via IFI27 upregulation","volume":"20","author":"Sagou","year":"2024","journal-title":"PLoS Pathog."},{"issue":"11","key":"10.1016\/j.intimp.2026.117310_bb0025","first-page":"ofad516","article-title":"EBV-encoded MicroRNA-BART17-3p targets DDX3X and promotes EBV infection in EBV-associated T\/natural killer-cell lymphoproliferative diseases, open forum","volume":"10","author":"Jin","year":"2023","journal-title":"Infect. Dis."},{"issue":"8","key":"10.1016\/j.intimp.2026.117310_bb0030","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/s41416-025-03131-0","article-title":"LMP2A regulates S901 phosphorylation of EphA2 to maintain EBV latent infection in gastric cancer","volume":"133","author":"Shi","year":"2025","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2026.117310_bb0035","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41579-022-00770-5","article-title":"Epstein-Barr virus and multiple sclerosis","volume":"21","author":"Soldan","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.intimp.2026.117310_bb0040","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fmicb.2011.00005","article-title":"Epstein-barr virus, the immune system, and associated diseases","volume":"2","author":"Chen","year":"2011","journal-title":"Front. Microbiol."},{"issue":"11","key":"10.1016\/j.intimp.2026.117310_bb0045","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/s41579-019-0249-7","article-title":"Latency and lytic replication in Epstein-Barr virus-associated oncogenesis","volume":"17","author":"M\u00fcnz","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"issue":"15","key":"10.1016\/j.intimp.2026.117310_bb0050","doi-asserted-by":"crossref","first-page":"8606","DOI":"10.1128\/JVI.00805-13","article-title":"Constitutive interferon-inducible protein 16-inflammasome activation during Epstein-Barr virus latency I, II, and III in B and epithelial cells","volume":"87","author":"Ansari","year":"2013","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.intimp.2026.117310_bb0055","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/s41401-020-00603-2","article-title":"NOD-like receptors in autoimmune diseases","volume":"42","author":"Chen","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"issue":"7904","key":"10.1016\/j.intimp.2026.117310_bb0060","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41586-022-04467-w","article-title":"Structure of the NLRP3 decamer bound to the cytokine release inhibitor CRID3","volume":"604","author":"Hochheiser","year":"2022","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.intimp.2026.117310_bb0065","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.cell.2014.04.007","article-title":"Mechanisms and functions of inflammasomes","volume":"157","author":"Lamkanfi","year":"2014","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.intimp.2026.117310_bb0070","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2026.117310_bb0075","article-title":"Regulation of the NLRP3 Inflammasome by post-translational modifications and small molecules","volume":"11","author":"Seok","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117310_bb0080","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1034\/j.1600-065X.2000.917309.x","article-title":"Innate immune recognition: mechanisms and pathways","volume":"173","author":"Medzhitov","year":"2000","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2026.117310_bb0085","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.coviro.2015.02.007","article-title":"Inflammasome control of viral infection","volume":"12","author":"Lupfer","year":"2015","journal-title":"Curr. Opin. Virol."},{"issue":"Pt A","key":"10.1016\/j.intimp.2026.117310_bb0090","article-title":"Huopu Xialing decoction mitigates influenza A-induced pulmonary injury by inhibiting METTL3-Nlrp3(m(6)a) mediated NLRP3 inflammasome activation","volume":"355","author":"Ou","year":"2026","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117310_bb0095","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13046-025-03358-y","article-title":"Viral expression of NE\/PPE enhances anti-colorectal cancer efficacy of oncolytic adenovirus by promoting TAM M1 polarization to reverse insufficient effector memory\/effector CD8(+) T cell infiltration","volume":"44","author":"Wang","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2026.117310_bb0100","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.3389\/fimmu.2019.02791","article-title":"Adenovirus VA RNAI blocks ASC oligomerization and inhibits NLRP3 Inflammasome activation","volume":"10","author":"Darweesh","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117310_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.178117","article-title":"Usnoflast: a cutting-edge NLRP3 inhibitor attenuates colonic inflammation across diverse immunopathology","volume":"1006","author":"Sharma","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117310_bb0110","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41522-023-00374-8","article-title":"Gut microbiota-mediated secondary bile acid alleviates Staphylococcus aureus-induced mastitis through the TGR5-cAMP-PKA-NF-\u03baB\/NLRP3 pathways in mice","volume":"9","author":"Zhao","year":"2023","journal-title":"NPJ Biofilms Microbiomes"},{"key":"10.1016\/j.intimp.2026.117310_bb0115","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.2147\/JIR.S454221","article-title":"Honokiol exhibits anti-NLRP3 Inflammasome and antimicrobial properties in Neisseria gonorrhoeae-infected macrophages","volume":"17","author":"Hua","year":"2024","journal-title":"J. Inflamm. Res."},{"issue":"5","key":"10.1016\/j.intimp.2026.117310_bb0120","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00818-25","article-title":"NLRP11 is required for canonical NLRP3 and non-canonical inflammasome activation during human macrophage infection with mycobacteria","volume":"16","author":"Szczerba","year":"2025","journal-title":"mBio"},{"issue":"4","key":"10.1016\/j.intimp.2026.117310_bb0125","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.immuni.2023.03.003","article-title":"The orphan receptor Nur77 binds cytoplasmic LPS to activate the non-canonical NLRP3 inflammasome","volume":"56","author":"Zhu","year":"2023","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.intimp.2026.117310_bb0130","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1182\/bloodadvances.2019001169","article-title":"Inflammatory signaling in dengue-infected platelets requires translation and secretion of nonstructural protein 1","volume":"4","author":"Quirino-Teixeira","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.intimp.2026.117310_bb0135","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3389\/fcvm.2020.00095","article-title":"NLRP3 Inflammasome signaling as a link between HIV-1 infection and atherosclerotic cardiovascular disease","volume":"7","author":"Mullis","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"issue":"7","key":"10.1016\/j.intimp.2026.117310_bb0140","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1182\/bloodadvances.2021005949","article-title":"Inflammasome activation in neutrophils of patients with severe COVID-19","volume":"6","author":"Aymonnier","year":"2022","journal-title":"Blood Adv."},{"issue":"13","key":"10.1016\/j.intimp.2026.117310_bb0145","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1016\/j.molcel.2023.05.018","article-title":"An Epstein-Barr virus protein interaction map reveals NLRP3 inflammasome evasion via MAVS UFMylation","volume":"83","author":"Yiu","year":"2023","journal-title":"Mol. Cell"},{"issue":"10","key":"10.1016\/j.intimp.2026.117310_bb0150","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1002\/eji.201545772","article-title":"Caspase-11 activates a canonical NLRP3 inflammasome by promoting K(+) efflux","volume":"45","author":"R\u00fchl","year":"2015","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2026.117310_bb0155","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/s41590-026-02468-9","article-title":"Author correction: silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization","volume":"27","author":"Hornung","year":"2026","journal-title":"Nat. Immunol."},{"issue":"7329","key":"10.1016\/j.intimp.2026.117310_bb0160","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09663","article-title":"A role for mitochondria in NLRP3 inflammasome activation","volume":"469","author":"Zhou","year":"2011","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.intimp.2026.117310_bb0165","doi-asserted-by":"crossref","first-page":"C83","DOI":"10.1152\/ajpcell.00298.2015","article-title":"NLRP3 inflammasome signaling is activated by low-level lysosome disruption but inhibited by extensive lysosome disruption: roles for K+ efflux and Ca2+ influx","volume":"311","author":"Katsnelson","year":"2016","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"2","key":"10.1016\/j.intimp.2026.117310_bb0170","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.immuni.2013.08.001","article-title":"Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation","volume":"39","author":"Iyer","year":"2013","journal-title":"Immunity"},{"issue":"7734","key":"10.1016\/j.intimp.2026.117310_bb0175","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41586-018-0761-3","article-title":"PtdIns4P on dispersed trans-Golgi network mediates NLRP3 inflammasome activation","volume":"564","author":"Chen","year":"2018","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.intimp.2026.117310_bb0180","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41419-019-1413-8","article-title":"Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors","volume":"10","author":"Yang","year":"2019","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.intimp.2026.117310_bb0185","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/cmi.2016.29","article-title":"Post-translational regulation of inflammasomes","volume":"14","author":"Yang","year":"2017","journal-title":"Cell. Mol. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2026.117310_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102024","article-title":"The central inflammasome adaptor protein ASC activates the inflammasome after transition from a soluble to an insoluble state","volume":"298","author":"Prather","year":"2022","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.intimp.2026.117310_bb0195","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.cell.2020.02.002","article-title":"Structural mechanism for GSDMD targeting by autoprocessed caspases in pyroptosis","volume":"180","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2026.117310_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2023.147888","article-title":"RNA-seq revealed the anti-pyroptotic effect of suramin by suppressing NLRP3\/caspase-1\/GSDMD pathway in LPS-induced MH-S alveolar macrophages","volume":"893","author":"Zhu","year":"2024","journal-title":"Gene"},{"key":"10.1016\/j.intimp.2026.117310_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105748","article-title":"Cucurbitacin B inhibits non-small cell lung cancer in vivo and in vitro by triggering TLR4\/NLRP3\/GSDMD-dependent pyroptosis","volume":"170","author":"Yuan","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.intimp.2026.117310_bb0210","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41420-022-01101-6","article-title":"Emerging mechanisms of pyroptosis and its therapeutic strategy in cancer","volume":"8","author":"Lu","year":"2022","journal-title":"Cell Death Discov."},{"issue":"D 1","key":"10.1016\/j.intimp.2026.117310_bb0215","first-page":"D 1670","article-title":"Generic Diagramming Platform (GDP): a comprehensive database of high-quality biomedical graphics","volume":"53","author":"iang S","year":"2025","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.intimp.2026.117310_bb0220","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1073\/pnas.1919133117","article-title":"A promiscuous inflammasome sparks replication of a common tumor virus","volume":"117","author":"Burton","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.intimp.2026.117310_bb0225","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"19","key":"10.1016\/j.intimp.2026.117310_bb0230","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00842-18","article-title":"Sendai virus V protein inhibits the secretion of interleukin-1\u03b2 by preventing NLRP3 Inflammasome assembly","volume":"92","author":"Komatsu","year":"2018","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.intimp.2026.117310_bb0235","doi-asserted-by":"crossref","DOI":"10.3390\/v13122344","article-title":"Molecular basis of Epstein-Barr virus latency establishment and lytic reactivation","volume":"13","author":"Murata","year":"2021","journal-title":"Viruses"},{"issue":"1732","key":"10.1016\/j.intimp.2026.117310_bb0240","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2016.0270","article-title":"Epstein-Barr virus infection and nasopharyngeal carcinoma","volume":"372","author":"Tsao","year":"2017","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2026.117310_bb0245","article-title":"Synthetic BZLF1-targeted transcriptional activator for efficient lytic induction therapy against EBV-associated epithelial cancers","volume":"15","author":"Wu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.117310_bb0250","first-page":"237","article-title":"Epstein-Barr virus lytic cycle reactivation","volume":"391","author":"McKenzie","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2026.117310_bb0255","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10040098","article-title":"The immunomodulatory capacity of an Epstein-Barr virus abortive lytic cycle: potential contribution to viral tumorigenesis","volume":"10","author":"Morales-S\u00e1nchez","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.intimp.2026.117310_bb0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011934","article-title":"EBV abortive lytic cycle promotes nasopharyngeal carcinoma progression through recruiting monocytes and regulating their directed differentiation","volume":"20","author":"Xu","year":"2024","journal-title":"PLoS Pathog."},{"issue":"12","key":"10.1016\/j.intimp.2026.117310_bb0265","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.tim.2024.05.007","article-title":"KAP1\/TRIM28 - antiviral and proviral protagonist of herpesvirus biology","volume":"32","author":"Bhaduri-McIntosh","year":"2024","journal-title":"Trends Microbiol."},{"issue":"5","key":"10.1016\/j.intimp.2026.117310_bb0270","doi-asserted-by":"crossref","DOI":"10.3390\/v13050846","article-title":"Inflammasome, the constitutive heterochromatin machinery, and replication of an oncogenic herpesvirus","volume":"13","author":"Bhaduri-McIntosh","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.intimp.2026.117310_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107496","article-title":"Cathepsin B aggravates acute pancreatitis by activating the NLRP3 inflammasome and promoting the caspase-1-induced pyroptosis","volume":"94","author":"Wang","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2026.117310_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2022.129093","article-title":"Co-exposure of chronic stress and alumina nanoparticles aggravates hippocampal microglia pyroptosis by activating cathepsin B\/NLRP3 signaling pathway","volume":"436","author":"Zhang","year":"2022","journal-title":"J. Hazard. Mater."},{"issue":"5","key":"10.1016\/j.intimp.2026.117310_bb0285","doi-asserted-by":"crossref","DOI":"10.1161\/ATVBAHA.125.322489","article-title":"Pulmonary vascular signaling in pulmonary hypertension: potential role of endothelial Ca(2+) signaling in cellular senescence and inflammasome activation","volume":"46","author":"Wang","year":"2026","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.intimp.2026.117310_bb0290","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.it.2018.01.009","article-title":"Orchestration of NLRP3 inflammasome activation by ion fluxes","volume":"39","author":"Gong","year":"2018","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117310_bb0295","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.immuni.2024.10.012","article-title":"Acute suppression of mitochondrial ATP production prevents apoptosis and provides an essential signal for NLRP3 inflammasome activation","volume":"58","author":"Saller","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2026.117310_bb0300","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3389\/fcell.2017.00090","article-title":"Role of cardiolipin in mitochondrial signaling pathways","volume":"5","author":"Dudek","year":"2017","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117310_bb0305","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41392-020-0151-9","article-title":"Drp1-dependent remodeling of mitochondrial morphology triggered by EBV-LMP1 increases cisplatin resistance","volume":"5","author":"Xie","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"3","key":"10.1016\/j.intimp.2026.117310_bb0310","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/s41593-025-01875-9","article-title":"CLEC16A in astrocytes promotes mitophagy and limits pathology in a multiple sclerosis mouse model","volume":"28","author":"Kadowaki","year":"2025","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.intimp.2026.117310_bb0315","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.semcancer.2012.01.004","article-title":"The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC)","volume":"22","author":"Dawson","year":"2012","journal-title":"Semin. Cancer Biol."},{"issue":"2","key":"10.1016\/j.intimp.2026.117310_bb0320","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/path.4575","article-title":"Activation of the FGFR1 signalling pathway by the Epstein-Barr virus-encoded LMP1 promotes aerobic glycolysis and transformation of human nasopharyngeal epithelial cells","volume":"237","author":"Lo","year":"2015","journal-title":"J. Pathol."},{"issue":"11","key":"10.1016\/j.intimp.2026.117310_bb0325","doi-asserted-by":"crossref","DOI":"10.3390\/v16111660","article-title":"Decoding critical targets and signaling pathways in EBV-mediated diseases using large language models","volume":"16","author":"Yu","year":"2024","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.intimp.2026.117310_bb0330","doi-asserted-by":"crossref","DOI":"10.31083\/j.fbl2904160","article-title":"Activation of the MEK\/ERK pathway mediates the inhibitory effects of silvestrol on nasopharyngeal carcinoma cells via RAP1A, HK2, and GADD45A","volume":"29","author":"Yu","year":"2024","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"11","key":"10.1016\/j.intimp.2026.117310_bb0335","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1044712","article-title":"COX-2 promotes metastasis in nasopharyngeal carcinoma by mediating interactions between cancer cells and myeloid-derived suppressor cells","volume":"4","author":"Li","year":"2015","journal-title":"Oncoimmunology"},{"issue":"7","key":"10.1016\/j.intimp.2026.117310_bb0340","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1073\/pnas.1120542109","article-title":"Genome-wide siRNA screen for mediators of NF-\u03baB activation","volume":"109","author":"Gewurz","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.intimp.2026.117310_bb0345","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.semcancer.2012.01.010","article-title":"Regulation of suppressive function of myeloid-derived suppressor cells by CD4+ T cells","volume":"22","author":"Nagaraj","year":"2012","journal-title":"Semin. Cancer Biol."},{"issue":"9","key":"10.1016\/j.intimp.2026.117310_bb0350","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1002\/ijc.30232","article-title":"Myeloid-derived suppressor cells as effectors of immune suppression in cancer","volume":"139","author":"Pyzer","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.intimp.2026.117310_bb0355","doi-asserted-by":"crossref","first-page":"12150","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.intimp.2026.117310_bb0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006503","article-title":"LMP1-mediated glycolysis induces myeloid-derived suppressor cell expansion in nasopharyngeal carcinoma","volume":"13","author":"Cai","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.intimp.2026.117310_bb0365","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3389\/fimmu.2020.00484","article-title":"Targeting inflammation driven by HMGB1","volume":"11","author":"Yang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117310_bb0370","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.virol.2021.12.002","article-title":"The danger molecule HMGB1 cooperates with the NLRP3 inflammasome to sustain expression of the EBV lytic switch protein in Burkitt lymphoma cells","volume":"566","author":"Reinhart","year":"2022","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.intimp.2026.117310_bb0375","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.cell.2013.02.054","article-title":"The adaptor MAVS promotes NLRP3 mitochondrial localization and inflammasome activation","volume":"153","author":"Subramanian","year":"2013","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.intimp.2026.117310_bb0380","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/s41590-022-01199-x","article-title":"KSHV-encoded ORF45 activates human NLRP1 inflammasome","volume":"23","author":"Yang","year":"2022","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2026.117310_bb0385","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s12223-025-01388-9","article-title":"Epstein-Barr virus and human miRNAs crosstalk: orchestrating latency, lytic cycle, and immune system modulation","volume":"71","author":"Mansour","year":"2026","journal-title":"Folia Microbiol (Praha)"},{"issue":"8","key":"10.1016\/j.intimp.2026.117310_bb0390","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.4049\/jimmunol.1200312","article-title":"Cutting edge: miR-223 and EBV miR-BART15 regulate the NLRP3 inflammasome and IL-1\u03b2 production","volume":"189","author":"Haneklaus","year":"2012","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2026.117310_bb0395","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001338","article-title":"Epstein-Barr virus infection of polarized epithelial cells via the basolateral surface by memory B cell-mediated transfer infection","volume":"7","author":"Shannon-Lowe","year":"2011","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.intimp.2026.117310_bb0400","doi-asserted-by":"crossref","first-page":"2519703","DOI":"10.1080\/19490976.2025.2519703","article-title":"Gastrointestinal inflammation and cancer: viral and bacterial interplay","volume":"17","author":"Arr\u00e8","year":"2025","journal-title":"Gut Microbes"},{"issue":"1","key":"10.1016\/j.intimp.2026.117310_bb0405","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12935-021-01793-3","article-title":"Signaling pathways of EBV-induced oncogenesis","volume":"21","author":"Luo","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"4","key":"10.1016\/j.intimp.2026.117310_bb0410","doi-asserted-by":"crossref","DOI":"10.3390\/v15040832","article-title":"Epstein-Barr virus B cell growth transformation: the nuclear events","volume":"15","author":"Zhao","year":"2023","journal-title":"Viruses"},{"issue":"11","key":"10.1016\/j.intimp.2026.117310_bb0415","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms8111824","article-title":"Epstein-Barr virus: how its lytic phase contributes to oncogenesis","volume":"8","author":"Rosemarie","year":"2020","journal-title":"Microorganisms"},{"issue":"Pt 1","key":"10.1016\/j.intimp.2026.117310_bb0420","first-page":"267","article-title":"Burkitt\u2019s Lymphoma","volume":"390","author":"Rochford","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2026.117310_bb0425","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nrc.2016.92","article-title":"Epstein-Barr virus: more than 50 years old and still providing surprises","volume":"16","author":"Young","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.intimp.2026.117310_bb0430","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.3389\/fmicb.2016.01602","article-title":"Epstein-Barr virus: diseases linked to infection and transformation","volume":"7","author":"Jha","year":"2016","journal-title":"Front. Microbiol."},{"issue":"10192","key":"10.1016\/j.intimp.2026.117310_bb0435","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","article-title":"Nasopharyngeal carcinoma","volume":"394","author":"Chen","year":"2019","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.intimp.2026.117310_bb0440","first-page":"1215","article-title":"Expressions of NLRP3, Caspase-1, and GSDMD in nasopharyngeal carcinoma tissue and association with recurrence and metastasis","volume":"58","author":"Liu","year":"2023","journal-title":"Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi"},{"issue":"12","key":"10.1016\/j.intimp.2026.117310_bb0445","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/emmm.201201569","article-title":"Tumour inflammasome-derived IL-1\u03b2 recruits neutrophils and improves local recurrence-free survival in EBV-induced nasopharyngeal carcinoma","volume":"4","author":"Chen","year":"2012","journal-title":"EMBO Mol. Med."},{"issue":"8737","key":"10.1016\/j.intimp.2026.117310_bb0450","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/0140-6736(91)90943-J","article-title":"Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin\u2019s disease","volume":"337","author":"Pallesen","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2026.117310_bb0455","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.freeradbiomed.2021.11.036","article-title":"Advanced glycation end products and their related signaling cascades in adult survivors of childhood Hodgkin lymphoma: a possible role in the onset of late complications","volume":"178","author":"Felicetti","year":"2022","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.intimp.2026.117310_bb0460","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25042369","article-title":"Unraveling the role of the NLRP3 Inflammasome in lymphoma: implications in pathogenesis and therapeutic strategies","volume":"25","author":"Stergiou","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"20","key":"10.1016\/j.intimp.2026.117310_bb0465","doi-asserted-by":"crossref","first-page":"6339","DOI":"10.1182\/bloodadvances.2023010330","article-title":"Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b\/2 study","volume":"7","author":"Haverkos","year":"2023","journal-title":"Blood Adv."},{"issue":"2","key":"10.1016\/j.intimp.2026.117310_bb0470","doi-asserted-by":"crossref","DOI":"10.1093\/narcan\/zcaf017","article-title":"Leveraging the interconnected unfolded protein response and NLRP3 inflammasome pathways to reactivate Epstein-Barr virus in diffuse large B-cell lymphomas","volume":"7","author":"Xu","year":"2025","journal-title":"NAR Cancer"},{"issue":"2","key":"10.1016\/j.intimp.2026.117310_bb0475","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000523","article-title":"Extranodal natural killer\/T-cell lymphoma, nasal type: diagnosis and treatment","volume":"5","author":"van Doesum","year":"2021","journal-title":"Hemasphere"},{"issue":"1","key":"10.1016\/j.intimp.2026.117310_bb0480","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13052-024-01685-y","article-title":"Clinical epidemiology of Epstein-Barr virus-associated lymphoproliferative disorders (EBV-LPDs) in hospitalized children: a six-year multi-institutional study in China","volume":"50","author":"Dilmurat","year":"2024","journal-title":"Ital. J. Pediatr."},{"issue":"2","key":"10.1016\/j.intimp.2026.117310_bb0485","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ijc.33802","article-title":"Disparity analysis and prognostic value of pretreatment whole blood Epstein-Barr virus DNA load and Epstein-Barr encoding region status in lymphomas: a retrospective multicenter study in Huaihai lymphoma working group","volume":"150","author":"Shen","year":"2022","journal-title":"Int. J. Cancer"},{"issue":"11","key":"10.1016\/j.intimp.2026.117310_bb0490","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1080\/10428194.2021.1933472","article-title":"Hsa-miR-372-5p regulates the NIMA related kinase 7 and IL-1\u03b2 release in NK\/T-cell lymphoma","volume":"62","author":"Chen","year":"2021","journal-title":"Leuk. Lymphoma"},{"issue":"2","key":"10.1016\/j.intimp.2026.117310_bb0495","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1080\/1040841X.2024.2344114","article-title":"The role of Epstein-Barr virus in autoimmune and autoinflammatory diseases","volume":"51","author":"Borghol","year":"2025","journal-title":"Crit. Rev. Microbiol."},{"issue":"6578","key":"10.1016\/j.intimp.2026.117310_bb0500","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.intimp.2026.117310_bb0505","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1093\/brain\/awaa084","article-title":"NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients","volume":"143","author":"Malhotra","year":"2020","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.intimp.2026.117310_bb0510","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1093\/brain\/awaa135","article-title":"The NLRP3 inflammasome in progressive multiple sclerosis","volume":"143","author":"Kadowaki","year":"2020","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.intimp.2026.117310_bb0515","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/bpa.12477","article-title":"Inflammasome activation in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE)","volume":"27","author":"Barclay","year":"2017","journal-title":"Brain Pathol."},{"issue":"6","key":"10.1016\/j.intimp.2026.117310_bb0520","doi-asserted-by":"crossref","first-page":"E1194","DOI":"10.1073\/pnas.1714948115","article-title":"IL-1\u03b2 enables CNS access to CCR2(hi) monocytes and the generation of pathogenic cells through GM-CSF released by CNS endothelial cells","volume":"115","author":"Par\u00e9","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"29","key":"10.1016\/j.intimp.2026.117310_bb0525","doi-asserted-by":"crossref","first-page":"12105","DOI":"10.1523\/JNEUROSCI.5369-12.2013","article-title":"Interleukin-1\u03b2 alters glutamate transmission at Purkinje cell synapses in a mouse model of multiple sclerosis","volume":"33","author":"Mandolesi","year":"2013","journal-title":"J. Neurosci."},{"issue":"39","key":"10.1016\/j.intimp.2026.117310_bb0530","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aav1447","article-title":"Gasdermin D activity in inflammation and host defense","volume":"4","author":"Lieberman","year":"2019","journal-title":"Sci. Immunol."},{"issue":"6281","key":"10.1016\/j.intimp.2026.117310_bb0535","doi-asserted-by":"crossref","first-page":"aaf2154","DOI":"10.1126\/science.aaf2154","article-title":"Programmed necrosis in inflammation: toward identification of the effector molecules","volume":"352","author":"Wallach","year":"2016","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.intimp.2026.117310_bb0540","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29960","article-title":"Analysis of the epidemiology and clinical characteristics of Epstein-Barr virus infection","volume":"96","author":"Ding","year":"2024","journal-title":"J. Med. Virol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117310_bb0545","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s43556-023-00137-z","article-title":"hMSCs treatment attenuates murine herpesvirus-68 (MHV-68) pneumonia through altering innate immune response via ROS\/NLRP3 signaling pathway","volume":"4","author":"Qin","year":"2023","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.intimp.2026.117310_bb0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175091","article-title":"Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome","volume":"928","author":"Li","year":"2022","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.intimp.2026.117310_bb0555","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms8101459","article-title":"Role of infections in the pathogenesis of rheumatoid arthritis: focus on mycobacteria","volume":"8","author":"Bo","year":"2020","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.intimp.2026.117310_bb0560","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26010197","article-title":"Differences in salivary cytokinome and pathogen load between rheumatoid arthritis and other rheumatic disease patients","volume":"26","author":"Korzeniowska","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2026.117310_bb0565","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1086\/428097","article-title":"Long-term shedding of infectious Epstein-Barr virus after infectious mononucleosis","volume":"191","author":"Fafi-Kremer","year":"2005","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.intimp.2026.117310_bb0570","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/art.41994","article-title":"Antibody responses to Epstein-Barr virus in the preclinical period of rheumatoid arthritis suggest the presence of increased viral reactivation cycles","volume":"74","author":"Fechtner","year":"2022","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.intimp.2026.117310_bb0575","first-page":"iii2-iii9","article-title":"The role of interleukin-1 in the pathogenesis of rheumatoid arthritis","volume":"43 Suppl 3","author":"Kay","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.intimp.2026.117310_bb0580","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13256-015-0603-y","article-title":"Efficacy of inhibition of IL-1 in patients with rheumatoid arthritis and type 2 diabetes mellitus: two case reports and review of the literature","volume":"9","author":"Ruscitti","year":"2015","journal-title":"J Med Case Reports"},{"issue":"11","key":"10.1016\/j.intimp.2026.117310_bb0585","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1172\/JCI36389","article-title":"Evidence that cytokines play a role in rheumatoid arthritis","volume":"118","author":"Brennan","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2026.117310_bb0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105699","article-title":"Shikonin, an inhibitor of inflammasomes, inhibits Epstein-Barr virus reactivation","volume":"217","author":"Borde","year":"2023","journal-title":"Antiviral Res."},{"issue":"4","key":"10.1016\/j.intimp.2026.117310_bb0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114070","article-title":"NLRP3 Cys126 palmitoylation by ZDHHC7 promotes inflammasome activation","volume":"43","author":"Yu","year":"2024","journal-title":"Cell Rep."},{"issue":"9","key":"10.1016\/j.intimp.2026.117310_bb0600","first-page":"1058","article-title":"Jasurolignoside from Ilex pubescens exerts a therapeutic effect on acute lung injury in vitro and in vivo by binding to TLR4","volume":"23","author":"Han","year":"2025","journal-title":"Chin. J. Nat. Med."},{"issue":"2","key":"10.1016\/j.intimp.2026.117310_bb0605","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jep.2012.07.033","article-title":"Compatibility art of traditional Chinese medicine: from the perspective of herb pairs","volume":"143","author":"Wang","year":"2012","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2026.117310_bb0610","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jare.2024.08.005","article-title":"Development of modern Chinese medicine guided by molecular compatibility theory","volume":"73","author":"Luo","year":"2025","journal-title":"J. Adv. Res."},{"issue":"4","key":"10.1016\/j.intimp.2026.117310_bb0615","doi-asserted-by":"crossref","DOI":"10.3390\/ph18040468","article-title":"Aromatic molecular compatibility attenuates influenza virus-induced acute lung injury via the lung-gut axis and lipid droplet modulation","volume":"18","author":"Li","year":"2025","journal-title":"Pharmaceuticals (Basel)"},{"issue":"3","key":"10.1016\/j.intimp.2026.117310_bb0620","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3892\/mmr.2012.959","article-title":"Parthenolide induces apoptosis and lytic cytotoxicity in Epstein-Barr virus-positive Burkitt lymphoma","volume":"6","author":"Li","year":"2012","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2026.117310_bb0625","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s10020-024-00917-5","article-title":"Parthenolide ameliorates 3-nitropropionic acid-induced Huntington\u2019s disease-like aberrations via modulating NLRP3 inflammasome, reducing microglial activation and inducing astrocyte shifting","volume":"30","author":"Noureldeen","year":"2024","journal-title":"Mol. Med."},{"issue":"9","key":"10.1016\/j.intimp.2026.117310_bb0630","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00109-018-1644-7","article-title":"Klotho preservation by Rhein promotes toll-like receptor 4 proteolysis and attenuates lipopolysaccharide-induced acute kidney injury","volume":"96","author":"Bi","year":"2018","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.intimp.2026.117310_bb0635","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.3389\/fphar.2019.01600","article-title":"Rhein suppresses lung inflammatory injury induced by human respiratory syncytial virus through inhibiting NLRP3 inflammasome activation via NF-\u03baB pathway in mice","volume":"10","author":"Shen","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.intimp.2026.117310_bb0640","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/s41419-023-06382-y","article-title":"The multifaceted roles of GSDME-mediated pyroptosis in cancer: therapeutic strategies and persisting obstacles","volume":"14","author":"Hu","year":"2023","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.intimp.2026.117310_bb0645","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s13046-021-02065-8","article-title":"Pyroptosis at the forefront of anticancer immunity","volume":"40","author":"Loveless","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.intimp.2026.117310_bb0650","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202006599","article-title":"A virus-spike tumor-activatable pyroptotic agent","volume":"17","author":"Nadeem","year":"2021","journal-title":"Small"},{"issue":"30","key":"10.1016\/j.intimp.2026.117310_bb0655","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202501157","article-title":"Microwave-responsive AlEu-MOFs potentiate NLRP3-mediated pyroptosis via a \u201ctriple initiating\u201d tactic for breast cancer microwave-immunotherapy","volume":"21","author":"Wu","year":"2025","journal-title":"Small"},{"issue":"4","key":"10.1016\/j.intimp.2026.117310_bb0660","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41565-025-01857-9","article-title":"Tandem-controlled lysosomal assembly of nanofibres induces pyroptosis for cancer immunotherapy","volume":"20","author":"Zhang","year":"2025","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117310_bb0665","article-title":"Programmed enhancement of endogenous iron-mediated lysosomal membrane permeabilization for tumor ferroptosis\/pyroptosis dual-induction","volume":"16","author":"Zhu","year":"2025","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.intimp.2026.117310_bb0670","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41565-018-0274-0","article-title":"Physical activation of innate immunity by spiky particles","volume":"13","author":"Wang","year":"2018","journal-title":"Nat. Nanotechnol."},{"issue":"3","key":"10.1016\/j.intimp.2026.117310_bb0675","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202406790","article-title":"Reprogrammed Lung metastasis immunodeficiency via targeted penetrated delivery of M1 macrophage-wrapped NanoCubes-mediated T cell infiltration","volume":"21","author":"Wang","year":"2025","journal-title":"Small"},{"issue":"1","key":"10.1016\/j.intimp.2026.117310_bb0680","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12951-025-03789-x","article-title":"Hollow spiky MnOx nanocarriers amplify radiotherapy-induced pyroptosis for eliciting antitumor immunity","volume":"24","author":"Zhang","year":"2025","journal-title":"J. Nanobiotechnology"},{"issue":"6","key":"10.1016\/j.intimp.2026.117310_bb0685","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/1348-0421.13063","article-title":"Human cytomegalovirus infection activates NLRP3 inflammasome by releasing mtDNA into the cytosol in human THP-1 cells","volume":"67","author":"Xu","year":"2023","journal-title":"Microbiol. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2026.117310_bb0690","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008335","article-title":"STING promotes NLRP3 localization in ER and facilitates NLRP3 deubiquitination to activate the inflammasome upon HSV-1 infection","volume":"16","author":"Wang","year":"2020","journal-title":"PLoS Pathog."},{"issue":"6015","key":"10.1016\/j.intimp.2026.117310_bb0695","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1126\/science.1199478","article-title":"Discovery of a viral NLR homolog that inhibits the inflammasome","volume":"331","author":"Gregory","year":"2011","journal-title":"Science"}],"updated-by":[{"DOI":"10.1016\/j.intimp.2026.117420","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000}}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926011574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926011574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:32:45Z","timestamp":1790436765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926011574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":139,"alternative-id":["S1567576926011574"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117310","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NLRP3 inflammasome and Epstein\u2013Barr virus: mutual regulation and therapeutic potential","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117310","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117310"}}